Maja Gvozdenov

Istraživač saradnik
Laboratorija za molekularnu biologiju (LMB)

Institut za molekularnu genetiku i genetičko inženjerstvo (IMGGI),
Univerzitet u Beogradu (UB),

V. Stepe 444a, 11010 Beograd, Srbija
Mob: +381 64 397 66 58
Tel:  +381 11 397 66 58
Fax:    +381 11 397 58 08
E-mail: maja@imgge.bg.ac.rs

OBRAZOVANJ

2017 - Doktor bioloških nauka, Biološki fakultet (BF), Univerzitet u Beogradu (UB): „Funkcionalna analiza genskih varijanti FIIc.1787G>A (protrombin Beograd) i FIIc.*64_*66del i njihova povezanost sa trombofilijom
2012
- Student doktorskih studija, modul molekularna biologija eukariota, Biološki fakultet, UB
2012 - Master molekularni biolog i fiziolog, Biološki fakultet, UB
2010 - Molekularni biolog i fiziolog, Biološki fakultet, UB

ISTRAŽIVAČKO ISKUSTVO

2014 - Istraživač saradnik, LMB, IMGGI, UB
2013 - 2014 - Istraživač pripravnik, LMB, IMGGI, UB
2012 - 2013 - Volonter LMB, IMGGI, UB
2011 - 2012 - Master student, Laboratorija za kardiovaskularnu fiziologiju, Institut za medicinska istraživanja, UB

OBLAST NAUČNOG INTERESOVANJA

  • obrada 3'kraja protrombinskog gena i regulacija ekspresije gena za protrombin
  • uloga mikro RNK u ekspresiji protrombinskog gena
  • funkcionalna analiza genskih varijanti u 3'kraju gena za prothrombin
  • 3'kraj prothrombinskog gena u etiologiji trombofilije, kancera i inflamacije
  • definisanje novih markera trombofilije
  • nasledna trombofilija

ODABRANI NAUČNI RADOVI

  1. Miljic P, Gvozdenov M, Takagi Y, Takagi A, Pruner I, Dragojevic M, Tomic B, Bodrozic J, Kojima T, Radojkovic D, Djordjevic V.Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism. J Thromb Haemost. 2017;15(4):670-7.
  2. Mitrovic M, Suvajdzic N, Elezovic I, Bogdanovic A, Djordjevic V, Miljic P,  Djunic I,  Gvozdenov M, Colovic N, Virijevic M, Lekovic D, Vidovic A, Tomin D. Thrombotic events in acute promyelocytic leukemia. Thromb Res. 2015; 135(4):588-93.
  3. Djordjevic V, Gvozdenov  M, Pruner I, Kovac  M,  Tomic B, Stankovic M, Radojkovic D.The prevalence of the PAI-1 4G/5G polymorphism in women with fetal loss – first data for Serbian population. J Med Bioch. 2014;33(2):203-8.
  4. Pruner I, Djordjevic V, Gvozdenov M,Tomic B, Radojkovic D. Determination of transgene copy number in stably transfected mammalian cells by PCR-capillary electrophoresis assay. Biochem Genet. 2014;52(3-4):159-65.
  5. Djordjevic V, Pruner I, Tomic B, Nestorovic A, Gvozdenov M, Kovac M, Radojkovic D. The 3' End Prothrombin Gene Variants in Patients With Different Thrombotic Events. Lab Med. 2014;45:309-14.
  6. Gvozdenov M, Pruner I, Tomic B, Aradjanski M, Antonijevic N, Radojkovic D, Djordjevic V. Prothrombin 3’ end gene variants in isolated pulmonary embolism-the first report of  FIIc.*64_*66del and FIIc.*303T˃C variants. Acta Cardiol. 2015; 70(2):177-82.
  7. Aradjanski M, Djordjevic V, Pruner I, Tomic B, Gvozdenov M, Kovac M, Radojkovic  D. The 3' end prothrombin gene variants in Serbian patients with idiopathic thrombophilia. BJMG. 2015; 17(2):43-8.
  8. Gvozdenov M, Pruner I, Tomic B, Kovac M, Radojkovic D, Djordjevic V. The effect of FII c.1787G>A (prothrombin Belgrade) mutation on prothrombin gene expression in vitro. Mol Biol. 2017; 51(1):49–52.

Please publish modules in offcanvas position.